How should seborrheic dermatitis be diagnosed and treated?

Seborrheic Dermatitis: Diagnosis and Treatment

Diagnosis

Seborrheic dermatitis is a clinical diagnosis based on the presence of symmetric, poorly defined erythematous patches with yellow, oily scales and fine superficial desquamation, predominantly affecting sebaceous gland-rich areas including the scalp, face, chest, back, axilla, and groin 1, 2.

Key Diagnostic Features

• Location: Scalp, face (especially nasolabial folds, eyebrows, glabella), ears, chest, back, axilla, and groin 1, 3
• Appearance: Flaky, "greasy" patches and/or thin plaques with scaling 4
• Associated symptoms: Pruritus is common in many patients 4
• Skin tone considerations: In darker skin, erythema may be less apparent, and postinflammatory hypopigmentation or hyperpigmentation may be the presenting sign with slightly scaly areas 1, 5

Differential Diagnosis

Consider and exclude:

• Atopic dermatitis: May overlap, especially in infants; look for distribution patterns and family history 5
• Psoriasis: Thicker, more well-demarcated plaques with silvery scale 5
• Contact dermatitis: History of exposure to irritants or allergens 6
• Rosacea: Facial involvement with telangiectasias and papulopustular lesions 5

Laboratory investigations are seldom required as diagnosis is clinical 3. Skin biopsy is generally not helpful 6.

Treatment

Scalp Seborrheic Dermatitis

First-line treatment consists of topical over-the-counter antifungal shampoos 1, 2.

Antifungal Agents (Primary Treatment)

• Ketoconazole shampoo: Most studied and effective antifungal option 3, 2
• Ciclopirox shampoo: Alternative antifungal agent 3
• Miconazole: Another topical antifungal option 3

Second-Line Agents

• Topical corticosteroids (short-term use only): Prescription-strength solutions, foams, or oils for moderate-to-severe cases 1, 3
  • Use mild-to-moderate potency preparations 3
  • Limit duration due to potential adverse effects including pituitary-adrenal suppression 6

Adjunctive Therapy

• Keratolytic agents: For thick, scaly areas, use keratolytic shampoos and lotions containing propylene glycol 1, 3

Facial and Body Seborrheic Dermatitis

Topical antifungal agents are the mainstay of therapy for face and body involvement 2, 7.

First-Line Treatment

• Topical ketoconazole cream: Primary antifungal option 3, 2
• Ciclopirox cream: Alternative antifungal 3
• Clotrimazole cream: Another antifungal option 3

Anti-Inflammatory Agents (Short-Term Use)

• Mild-to-moderate potency topical corticosteroids: Use for short durations only due to possible adverse effects including skin atrophy 6, 1, 2
• Topical calcineurin inhibitors (tacrolimus, pimecrolimus): Off-label use for facial involvement, particularly useful for avoiding corticosteroid side effects 3, 2, 7
  • Should be used under dermatologist supervision 6

Alternative Agents

• Lithium succinate/gluconate: Topical option for facial or body areas 3
• Roflumilast 0.3% foam: New topical phosphodiesterase-4 inhibitor showing promise as a noncorticosteroid option 7

Severe or Resistant Cases

For severe and/or treatment-resistant seborrheic dermatitis, consider systemic therapies 3, 7:

• Systemic antifungal agents: Terbinafine or itraconazole 3
• UVB phototherapy: May be considered for refractory cases 3
• Narrowband UVB (TL-01): Has shown efficacy in open studies 6

Neonatal Seborrheic Dermatitis (Cradle Cap)

Neonatal seborrheic dermatitis is typically self-resolving by 6 months of age 1.

Mild Cases

• Conservative management: Mineral oil to loosen scale followed by gentle combing 1
• Baby shampoos: Enriched with emollient agents and vegetable oils 3

More Severe Cases

• Topical antifungals: If conservative measures fail 1
• Topical corticosteroids: For cases overlapping with atopic dermatitis 1
• Medical device shampoos: Containing piroctone olamine, bisabolol, alyglicera, or telmesteine 3

Treatment Principles

The basic principle is to use the least potent preparation required to control the condition, with periodic treatment breaks when possible 6.

• Frequency: Topical treatments should not be applied more than twice daily 6
• Long-term management: Antifungal agents can be used long-term, while corticosteroids should be limited to short-term use 2
• Combination approach: Treatment aims to modulate sebum production, reduce Malassezia colonization, and control inflammation 3, 7

Common Pitfalls

• Overuse of topical corticosteroids: Can lead to skin atrophy, perioral dermatitis, and pituitary-adrenal suppression 6
• Inadequate patient education: Demonstrate proper application techniques and provide written information 6
• Failure to recognize skin tone variations: In darker skin, look for postinflammatory pigmentary changes rather than relying solely on erythema 1, 5
• Misdiagnosis: Carefully differentiate from atopic dermatitis, psoriasis, and contact dermatitis 5